期刊文献+

肝星状细胞的免疫学特性 被引量:2

Immunological characteristics of hepatic stellate cells
下载PDF
导出
摘要 活化的肝星状细胞(hepatic stellate cells,HSCs)可合成大量细胞外基质(extracellular matrix,ECM),并可分泌转化生长因子β(transforming growth factor-β,TGF-β)、血小板源性生长因子(platelet derived growth factor,PDGF)等促纤维化因子,在肝纤维化的发生发展中起着关键作用。近来研究发现活化的肝星状细胞具有多种免疫细胞的特性,可直接参与肝脏局部免疫调控,而免疫因素在肝纤维化发病机制中占据着重要地位,因此深刻认识肝星状细胞的免疫学特征有助于进一步阐明肝纤维化的发病机制。 Activated hepatic stellate cells(HSCs) play a critical role in the progression of liver fibrosis through massive production of extracellular matrix(ECM) and profibrotic cytokines such as transforming growth factor β(TGF-β) and platelet derived growth factor(PDGF).Recently,some researches have confirmed that activated HSCs behave as immunocytes and are directly involved in local immune modulation.As immune factors greatly influence the process of human hepatic fibrosis,research on the immunological characteristics of HSCs will be very helpful in further clarifying the pathogenesis of this chronic and progressive disease.
作者 李婧 蒋炜
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2010年第3期364-367,共4页 Fudan University Journal of Medical Sciences
基金 上海市自然科学基金项目(09ZR1406000)
关键词 肝星状细胞 免疫学 肝纤维化 hepatic stellate cells immunology liver fibrosis
  • 相关文献

参考文献22

  • 1Paik YH,Lee KS,Lee HJ,et al.Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid[J].Lab Invest,2006,86(7):676-686.
  • 2Paik YH,Schwabe RF,Bataller R,et al.Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells[J].Hepatology,2003,37(5):1 043-1 055.
  • 3Isayama F,Hines IN,Kremer M,et al.LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice[J].Am J Physiol Gastrointest Liver Physiol,2006,290(6):1 318-1 328.
  • 4Gabele E,Muhlbauer M,Dorn C,et al.Role of TLR9 in hepatic stellate cells and experimental liver fibrosis[J].Biochem Biophys Res Commun,2008,376(2):271-276.
  • 5Vinas O,Bataller R,Sancho-Bru P,et al.Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation[J].Hepatology,2003,38(4):919-929.
  • 6Schwabe RF,Schnabl B,Kweon YO,et al.CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells[J].J Immunol,2001,166(11):6 812-6 819.
  • 7Jiang G,Yang HR,Wang L,et al.Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner[J].Transplantation,2008,86(11):1 492-1 502.
  • 8Winau F,Hegasy G,Weiskirchen R,et al.Ito cells are liver-resident antigen-presenting cells for activating T cell responses[J].Immunity,2007,26(1):117-129.
  • 9Maubach G,Lim MC,Kumar S,et al.Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment[J].Biochim Biophys Acta,2007,1 773(2):219-231.
  • 10Yu MC,Chen CH,Liang X,et al.Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice[J].Hepatology,2004,40(6):1 312-1 321.

同被引文献40

  • 1Sandrin L,Fourquet B,Hasquenoph JM,et al.Transient elas-tography:a new noninvasive met hod for assessment of hepatic fibrosis [J].UltrasotmdMed Bio 1,2003;67(3): 1132- 1134.
  • 2NKC Institute of Gastroenterology and Hepatology.Reviews for APASL guidelines:immtmomodfla- therapy of chronic hepafilis B[J].Hepatol Ira.,2008;2(2): 140-146.
  • 3Benhamou Y, Di Martino V, Boehet M,et al.Faetors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients:impact ofprotease inhibitor therapy[J].Hepatology,2001 ;34:283-287.
  • 4Feng XH,Derynck R.Specificity and versatility intgf-beta signaling through Smads[J].Annu Rev Cell Dev Biol,2005;21:659-693.
  • 5Weng HL,Wang BE,Jia JD,et al.Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection:a randomized contorned study[J].Clin Gastroenterol Hepato,2005;3(8):819-822.
  • 6Gupa GP,Massague J. Cancer metastasis building a frame work[J].Cell,2006,(04):679-695.
  • 7Prendergast GC,Jaffee EM. Cancer immunologists and cancer biologists:why we didn't talk then but need to now[J].Cancer Research,2007,(08):3500-3504.doi:10.1158/0008-5472.CAN-06-4626.
  • 8Yang JD,Nakamura I,Roberts LR. The tumor microenvironment in hepatocellular carcinoma:current status and therapeutic targets[J].Seminars in Cancer Biology,2011,(01):35-43.
  • 9Guo J,Friedman SL. Hepatic fibrogenesis[J].Seminars in Liver Disease,2007,(04):413-426.doi:10.1055/s-2007-991517.
  • 10Atzori L,Poli G,Perra A. Hepatic stellate cell:a star cell in the liver[J].International Journal of Biochemistry & Cell Biology,2009,(8-9):1639-1642.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部